Display # 
Title Author Hits
Could Time to Approval be Secondary? Written by Giora Davidai, MD 533
Quality with Good Intent Written by Julie Gerlach 480
Winter 1-2017 Newsletter Written by Kristi Hultberg 820
Presentation - Ed Allera, Esq. and Barbara Binzk Blumenfeld, Ph.D., M.A., Esq. Written by Ed Allera, Barbara Binzak 726
Newsletters Written by Kristi Hultberg 403
Hypoglycemia Evaluation and Reporting in Diabetes: Importance for the Development of New Therapies Written by David C. Klonoff et al. 1028
Round Table Discussion - Friday 1/20/17 Written by Dr. Fleming 532
Keys to Regulatory Operations Success Written by Sue Manley 489
FDA E-Submission Written by Steve Casey 522
Regulatory Perspectives From FDA Staff Written by Brian Harvey 726